These findings indicate that IL-4 and IL-13 are critical predictors of ACE levels in this patient group, suggesting a crucial role for Th2-mediated inflammatory responses in modulating the RAS system in the context of obesity and MASLD. Here, IL4 is linked to obesity due to melanocortin 4 receptor deficiency.